What is the Impact Factor of Cancer Genetics?

According to the latest Clarivate Journal Citation Reports (JCR), the Journal Impact Factor of Cancer Genetics is 11.0, ranking in quartile Q1 of Web of Science (SCIE).

Is Cancer Genetics indexed in Web of Science or Scopus?

Yes, Cancer Genetics is indexed in Web of Science (SCIE, Q1 quartile). Furthermore, in Scopus (SCImago), it holds an SJR rating of 1.251 (Q1) and an H-index of 59.

Who publishes Cancer Genetics and what is the Article Processing Charge (APC)?

Cancer Genetics is published by Elsevier BV. The estimated Article Processing Charge (APC) is approximately $3,162 USD, subject to institutional waivers and corresponding author affiliations.

What is the ISO-4 abbreviation and acronym of Cancer Genetics?

The official ISO-4 abbreviation of Cancer Genetics is "CANCER GENET-NY" with common acronym "cg". This standardized title abbreviation is used in citation lists conforming to IEEE, APA, Harvard, or Vancouver styles.

WoS SCIE Q1Scopus Q1SCImago #3,379Hybrid

Cancer Genetics

Acronym:cg

•

Abbreviation (ISO):CANCER GENET-NY

•

Identifier (ISSN):2210-7762(Print)/2210-7770(Online)

•

Publisher:Elsevier BV

Official Website Submission Portal Compare

Clarivate IF (2026)

11↑ +8.9

Journal Impact Factor

IF Trend↓

WoS Quartile

WoS SCIEJCR Quartile

Clarivate WoS JCR

WoS Categories↓

JCR Release Date: 2026-06-17

Impact Factor Trend (2018–2026)

Clarivate IF trend for Cancer Genetics

WoS Q1

Annual Impact Factor Metric

Current (2026):11

Scopus SJR & RankScopus Q1

1.251

#3,379

SCImago Journal Rank citation prestige weighting

Scopus Year: 2025

H-Index (2025)

59 papers with at least that number of citations each

WoS: SCIE / JCRQ1

Self-Citation Rate0%

Safe Level (< 15%)Warning Level (> 20%)

Self-citation below 15% indicates strong scholarly independence.

Volume & Open AccessHybrid

88articles/year

18.23% Gold OA•92.96% Original Research

Aims & Scope

The aim of Cancer Genetics is to publish high quality scientific papers on the cellular, genetic and molecular aspects of cancer, including cancer predisposition and clinical diagnostic applications. Specific areas of interest include descriptions of new chromosomal, molecular or epigenetic alterations in benign and malignant diseases; novel laboratory approaches for identification and characterization of chromosomal rearrangements or genomic alterations in cancer cells; correlation of genetic changes with pathology and clinical presentation; and the molecular genetics of cancer predisposition. To reach a basic science and clinical multidisciplinary audience, we welcome original full-length articles, reviews, meeting summaries, brief reports, and letters to the editor.

Topics Covered (Recognized by AI)

Biology87.1%Genetics82.5%Chemistry74.5%Biochemistry74%Medicine71.3%Gene71.2%Internal medicine59.9%Cancer research40.7%Pathology36.7%Cancer30.3%Immunology28.1%Chromosome25.8%Computational biology25.5%Oncology21.8%

Primary Research Areas

Oncology Genetics & Heredity

Official Website NLM PubMed Catalog Submission Portal SCImago Profile

0 calls

Special Issues

Calls for Papers

No active Calls for Papers found for this journal.

Expand

WoS Categories & Quartiles

Detailed JCR / JCI category rankings and quartile breakdown from Clarivate

Clarivate JCR & JCI

JCRSCIE2026

GENETICS & HEREDITY

Rank7/192

IndexSCIE

JCRSCIE2026

ONCOLOGY

Rank32/333

IndexSCIE

JCISCIE2026

GENETICS & HEREDITY

Rank19/192

IndexSCIE

JCISCIE2026

ONCOLOGY

Rank48/333

IndexSCIE

Category	Index	Rank	Quartile
GENETICS & HEREDITY	JCRSCIE	7/192	Q1
ONCOLOGY	JCRSCIE	32/333	Q1
GENETICS & HEREDITY	JCISCIE	19/192	Q1
ONCOLOGY	JCISCIE	48/333	Q1

Annual Historical Statistics & Publications

Track annual publication volume, total citations, and Impact Factor evolution

12 year

2026Latest

IF11

Articles / Year84

Total Citations16

2025

IF2.1

Articles / Year221

Total Citations529

2024

IF1.4

Articles / Year128

Total Citations932

2023

IF1.9

Articles / Year162

Total Citations647

2022

IF2.169

Articles / Year305

Total Citations533

Year	Impact Factor	Articles / Year	Total Citations
2026	11	84	16
2025	2.1	221	529
2024	1.4	128	932
2023	1.9	162	647
2022	2.169	305	533
2021	2.523	148	709
2020	3.105	136	895
2019	2.183	141	1,208
2018	2.351	176	1,212
2017	—	144	1,561
2016	—	215	1,313
2015	—	150	2,614

SCImago & Scopus Journal Intelligence

Global SCImago ranking, SJR prestige index, Scopus coverage, and societal policy impact

Rank #3,379Scopus Q1SCImago Profile

Scopus Coverage:2011-2026

•

Scopus Broad Areas:Biochemistry, Genetics and Molecular Biology

Scopus Citation Rank (SJR)Q1

1.251

Weighted prestige citation metric per document indexed in the Scopus database.

Quartile: Scopus Q1

Citations / Doc (2 years)

9.34

Average citations received per document published in the 2-year window.

2-Year Citation Window

Estimated Publication Fee (APC)

$3,162 USD

Estimated Article Processing Charge for Open Access publication.

Estimated cost / article

Scopus 3-Year Publication & Citation Window

3-Year Citations997

3-Year Documents166

Citable Documents164

Aggregated from Scopus database across the 3-year SJR evaluation window.

Societal Impact & Inclusivity (SCImago)

Policy Citations (Overton)0

Citations in government and international policy documents

Female Author Rate46.1%

Percentage of female authors published in the journal

Real-world societal policy reach and author gender diversity tracked by SCImago.

Scopus Subject Categories

GeneticsQ1

Cancer ResearchQ2

Molecular BiologyQ2

Academic Metric Intelligence

Journal Metrics & Citation Visualizations

Total Cites vs Self-Cites

Evaluation of scholarly independence and citation reach

Total citations steady growth

Self-citation: 0%

Citations per Document

Citation metric windows across 2, 3, and 4 years

Cites / Doc (4 years)Cites / Doc (3 years)Cites / Doc (2 years)

Chinese Academy of Sciences (CAS) Classification

Major / minor zone classification and CAS Early Warning List history

Major Category (Broad Field):

4区 (Zone 4)Medicine

Minor Category (Specific Field):

4区ONCOLOGY

CAS Early Warning List History:

Updated annually: 2020 – 2024

2020

Not warned

2021

Not warned

2022

Not warned

2023

Not warned

2024

Not warned

Academic Intelligence Overview & Context

ImpaQ Analysis

Cancer Genetics (acronym: cg, abbr: CANCER GENET-NY, ISSN: 2210-7762) is a peer-reviewed international scholarly journal in the field of ONCOLOGY, published by Elsevier BV in United States since 2011. The periodical holds a Journal Impact Factor (JIF) of 11.0, ranking in quartile Q1 of Web of Science (SCIE), a Scopus SJR indicator of 1.251 (Q1), an H-index of 59.

The journal enforces rigorous peer evaluation with an annual output of approximately 88 scientific articles. In terms of accessibility and author fees, it operates under the Hybrid model with an estimated APC of $3,162 USD. It serves as a benchmark publication platform for academics, researchers, and doctoral candidates seeking global research visibility.